May 18-20, 2006 Scottsdale, Arizona
- 3 Days, 22 Speakers, 280 learners, 22% of learners from outside the continental U.S., 8 Posters presented, 4 Prizes awarded for best research based on merit.
- Learner type: 63% RN, 16% NP, 5% Administrators, 3% LPN/LVN, 2% Pharmacist, 1% Physician, 1% Physician Assistant, 1% Social Worker, 1% Scientist, 7% Other
- Credit type: ANCC, ACCME, ACPE
- This educational activity was designed for nurses and support personnel interested in reproductive health and infertility care and encompassed current topics, ranging from eating disorders and their impact on fertility to disclosure in third party reproduction.
- 100% of learners reported that they would recommend this program to a colleague.
- 93% of learners reported that the content was free from commercial bias.
- Objectives for the course were to:
- Describe the challenges to effective clinical nursing practice by emerging research and new technologies in reproductive health care.
- Identify psychosocial, ethical and legal issues as they relate to assisted reproductive technologies.
- Incorporate new skills and concepts in reproductive health and infertility care into expert clinical nursing practice.
- BioSymposia Prize Poster Award went to Grand Prize Poster titled: “The Preservation of Fertility in Chemotherapy Patients: The Use of a Gonadotropin Releasing Hormone Antgonist (GnRH-antagonist) Cetrorelix for Ovarian Down-Regulation Prior to Chemotherapy”
- Concurrent tracks were offered: Novice nurses - fundamentals of embryology and reproductive endocrinology; Advanced practice nurses - advanced clinical topics; Operating room nurses and support personnel - OR essentials; Supervisors and Nurse Managers - SkillPath Management Seminar.
- Selected learner comments included:
“Great speakers - interesting information. I learned some great things!”
“The topics were very interesting and really provided opportunity for audience interaction.”
“Great way to network, great way to obtain current and interesting ways to practice.”
“Wide variety of relevant topics, something for nurses at all levels and different practices.”
“I would recommend this program for expert caliber of speakers and diversity of topics covered.”
“Informative, good topics - not just the norm - good way to network.”
“Very educational. However long you have been in the field there is always something new - finest speakers every time - great networking.”
“Interesting topics with opportunity to interact with other professionals.”
“There were several exceptional speakers this year who implemented humor in their presentations.”
“Amazing topics, wide variety of speakers, great location.”
“Excellent. As a pharmacist I have attended multiple pharmacy conference. This was probably the best conference I have attended in terms of content, organization, speakers and facility.”
“Nursing research! Good papers! Day 2 presenters were better than most at ASRM.”
“This conference was a 10/10. The speakers were outstanding and extremely informative.”
“Very well organized, good educational content. Program staff was very helpful and courteous.”
- Selected comments about the speakers included:
“The quality of speakers was topnotch - even better than expected.”
“Very informative - excellent speaker.”
“Controversial topic - always good for discussion.”
“Very knowledgeable and relaxed in front of everyone.”
“Better than very satisfied!”
“Very clear, very good speaker - please bring her back!”
“Interesting and informative. The speaker was fun and engaging.”
“Excellent! Informative! Will definitely seek more information.”
“This was excellent, great speaker, great information.”
“Excellent! Important subject - wonderful speaker.”
“Good overview with opportunity to ask questions. Delivered at right level.” “Wow! Amazing presentation and information. I feel honored to be present to hear him speak!”
“Held my attention - thought-provoking.”
“Just fantastic! Didn't want the talk to stop - excellent, excellent!”
Disclosure of Faculty Relationships
BioSymposia, Inc. (formerly Serono Symposia International, Inc.), adheres to guidelines of the Accreditation Council for Continuing Medical Education (ACCME), the American Nurses Credentialing Center’s Commission on Accreditation (ANCCCA), the Accreditation Council for Pharmacy Education (ACPE), and all other professional organizations as applicable, stating that programs where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
As uses for pharmaceutical agents, medical devices, and other products may be presented in the program that are not necessarily the same as those indicated in approved product labeling (but which may reflect clinical experience, professional literature, other clinical sources known to the presenter, or investigational uses of products), we ask the presenter to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is simply intended to inform participants of any potential conflicts so that participants may form their own judgments based on full disclosure of the facts. Further, these opinions and recommendations presented during the program or materials related to the program do not imply an endorsement or recommendation on the part of BioSymposia, Inc. These presentations solely represent the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-FDA approved (off-label) uses of drugs:
Clay Anselmo discloses that he is an employee of Reglera Corporation.
Barrett Cowan, M.D. discloses that he will discuss the off-label use of Clomiphene Citrate in a discussion of male infertility.
Diane Felblinger, Ed.D., M.S.N., W.H.N.P.-C., C.N.S., R.N. discloses that she is the recipient of a research grant from Procter and Gamble Pharmaceuticals.
Patricia Mendell, L.C.S.W., B.C.D. discloses that she is a consultant for, speaker for, and is a member of the Executive Board of the American Fertility Association.
Stephan Moll, M.D. discloses that he is a member of a speaker’s bureau for Sanofi-Aventis.
Ann Scalia, R.N., B.S.N., C.N.O.R. discloses that she is an employee of ivpcare, Inc.
The following faculty indicated no significant relationship with commercial supporters and/or discussion of investigational or non-FDA approved (off-label) uses of drugs:
Linda D. Applegarth, Ed.D., Susannah Baruch, J.D., Hannelore Conley, , M.S., R.N., C.N.P., Linda DeOrio, R.N.C., R.D.M.S., Dawn Duncan, R.N., Louis J. Guillette, Jr., Ph.D., Wendy D. Latash, Ph.D., Kelly Lehl, R.N., Vanessa Mendez Bellocq, Debra A. Minjarez, M.D., Debra Moynihan, R.N.C., A.P.N.-C., M.S.N., David Olive, M.D., Lori J. Pitzer, M.S.T.C.M., L.A.C., Catherine Racowsky, Ph.D., William Schoolcraft, M.D., Mary Jo Steiert, R.N., B.S.N., C.N.O.R., Anne M. Stone, R.D.M.S., and Kenneth Weiner, M.D.
Commercial Support and Other Disclosures
BioSymposia, Inc. (formerly Serono Symposia International, Inc.) is a 501(c)(3) nonprofit organization. All of our programs are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products. These views are the responsibility of the named speakers, and do not represent an endorsement or recommendation on the part of BioSymposia, Inc.
This program was supported by an unrestricted educational grant from Serono, Inc. BioSymposia, Inc. personnel are employees of Serono, Inc. and BioSymposia, Inc. also receives other in-kind support from Serono, Inc. in the form of space and administrative services.
